Daxor Corp Relocates Principal Executive Offices to Oak Ridge, TN

Ticker: DXR · Form: 8-K · Filed: Jan 2, 2024 · CIK: 27367

Daxor Corp 8-K Filing Summary
FieldDetail
CompanyDaxor Corp (DXR)
Form Type8-K
Filed DateJan 2, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: administrative, corporate-governance

TL;DR

**Daxor Corp moved its main office to Oak Ridge, TN; no big deal for the stock.**

AI Summary

Daxor Corporation filed an 8-K on January 2, 2024, to update its principal executive offices from 350 Fifth Avenue, Suite 4740, New York, NY 10118 to 109 Meco Lane, Oak Ridge, TN 37830. This change in address, effective January 2, 2024, is a minor administrative update and does not signal any operational or financial shifts. For investors, this simply means the company's physical headquarters has moved, which typically has no direct impact on the stock's value or the company's business operations.

Why It Matters

This filing indicates a change in Daxor Corporation's physical headquarters, which is an administrative update and does not reflect any changes in the company's financial health or business strategy.

Risk Assessment

Risk Level: low — The filing reports a routine administrative change of address, which carries minimal risk to investors.

Analyst Insight

A smart investor would note this administrative change but understand it has no direct bearing on Daxor's operational performance or financial outlook, thus requiring no immediate action regarding their investment.

Key Players & Entities

  • Daxor Corporation (company) — the registrant filing the 8-K
  • January 2, 2024 (date) — date of earliest event reported and filing date
  • 350 Fifth Avenue, Suite 4740, New York, NY 10118 (address) — Daxor's former business address
  • 109 Meco Lane, Oak Ridge, TN 37830 (address) — Daxor's new principal executive offices address
  • Nasdaq (company) — exchange where Daxor's Common Stock is registered
  • DXR (ticker) — trading symbol for Daxor's Common Stock

FAQ

What is the purpose of this 8-K filing by Daxor Corporation?

This 8-K filing by Daxor Corporation is to report a change in its principal executive offices, effective January 2, 2024, as indicated under 'Other Events' and 'Financial Statements and Exhibits'.

What was Daxor Corporation's previous principal executive office address?

Daxor Corporation's previous principal executive office address was 350 Fifth Avenue, Suite 4740, New York, NY 10118.

What is Daxor Corporation's new principal executive office address?

Daxor Corporation's new principal executive office address is 109 Meco Lane, Oak Ridge, TN 37830.

On what date did the change in Daxor Corporation's principal executive offices become effective?

The change in Daxor Corporation's principal executive offices became effective on January 2, 2024, which is also the date of the earliest event reported.

What is the trading symbol and exchange for Daxor Corporation's common stock?

The trading symbol for Daxor Corporation's common stock is DXR, and it is registered on Nasdaq.

Filing Stats: 506 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-01-02 08:52:42

Key Financial Figures

  • $0.01 — ange on which registered Common Stock $0.01 par value DXR Nasdaq Indicate by

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. DAXOR CORPORATION (Registrant) Date: January 2, 2024 By: /s/ Robert J. Michel Name: Robert J. Michel Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.